APPLICATION
ANDA074561
TYPE
ANDA
ORIGINAL APPROVAL
1996-08-15
LATEST ACTION
2000-02-02
ROUTE
ORAL
DOSAGE FORM
POWDER
MARKETING STATUS
Prescription
Products
LOCHOLESTPrescription
CHOLESTYRAMINE EQ 4GM RESIN/SCOOPFUL · POWDER · ORAL
LOCHOLESTPrescription
CHOLESTYRAMINE EQ 4GM RESIN/PACKET · POWDER · ORAL
Approval history
2000-02-02Manufacturing (CMC) · Supplement 4AP
1998-05-27Manufacturing (CMC) · Supplement 3AP
1997-05-29Labeling · Supplement 2AP
1996-10-08Labeling · Supplement 1AP
1996-08-15OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.